Polaryx Therapeutics, Inc Common Stock
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -974 | -884 | -5,052 | -723 |
Net Income | -1,430 | -1,008 | -5,052 | -723 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -887 | -858 | -709 | -860 |
Cash | 5,745 | 3,304 | 4,162 | 4,621 |
Basic Shares | 189,372 | 189,372 | 189,372 | 189,372 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 |
|---|---|---|
Revenue | $0 | $0 |
EBITDA | -4,352 | -3,781 |
Net Income | -30,356 | -3,779 |
Net Change In Cash | 0 | 0 |
Free Cash Flow | -2,573 | -173 |
Cash | 4,621 | 2 |
Basic Shares | 189,372 | 189,372 |
